BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Tekmira Pharmaceuticals Corporation 

100-8900 Glenlyon Parkway

Burnaby  British Columbia  V5J 5J8  Canada
Phone: 604-419-3200 Fax: 604-419-3201


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Tekmira (TKMR) Announces Update To Its Proxy Circular On The Proposed Business Combination With Oncore 2/26/2015 7:52:38 AM
Tekmira (TKMR) To Present At RBC Capital Markets' Healthcare Conference 2/13/2015 8:00:35 AM
Tekmira (TKMR) Announces Filing Of Definitive Proxy Statement And Voluntary Delisting From The TSX 2/5/2015 1:07:20 PM
Oncore And Tekmira (TKMR) Files For Merger – Releases Further Details About License Agreement With NeuroVive Pharmaceutical AB 2/5/2015 9:46:14 AM
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK) 1/21/2015 4:06:07 PM
Tekmira (TKMR) Initiates Phase I Clinical Trial Of TKM-HBV 1/21/2015 7:21:41 AM
NeuroVive Pharmaceutical AB: Merger Between Oncore And Tekmira (TKMR) Includes Development Of NVP018 For The Treatment Of Hepatitis B 1/20/2015 11:11:01 AM
Merger Between Oncore And Tekmira (TKMR) Includes Development Of NVP018 For The Treatment Of Hepatitis B 1/19/2015 10:39:53 AM
The New Billion Dollar Tekmira (TKMR) Includes Promising Hep B Drug 1/19/2015 7:47:24 AM
Tekmira (TKMR) And Oncore Announce Merger Agreement To Create Leading Global Hepatitis B Virus Company 1/12/2015 6:57:20 AM
12345678910...